ISSX Africa Workshop

Magnus Ingelman-Sundberg

Magnus Ingelman-Sundberg, PhD; BSc.Med is Professor of Molecular Toxicology and research group leader in Pharmacogenetics at the Department of Physiology and Pharmacology, Karolinska Institutet. He has more than 520 original papers and a h-factor of 100 (ISI/Clarivate) or 132 (Google Scholar). Assigned “Highly Cited Researcher” for 2014-2017 and 2021-2024  by Thomson & Reuters/Clarivate. He was a member of The Nobel Assembly at Karolinska Institutet 2008-2018. He has received numerous Awards, most recently the 2018 BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology, The RT Williams ISSX award and an honorary doctorship at SydDansk University. His research focuses on genetics, polymorphism, regulation, function and toxicology of the hepatic ADME system with aims at understanding interindividual differences in drug response. Furthermore, he develops novel hepatic in vitro systems for studying liver function, liver diseases and validation of hepatic drug targets.